Payden Equity Income Fund Adviser Cl
PYVAX · NASDAQ
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Market Cap | – | – | – | – |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | – | – | – | – |
| Revenue | $2,199 | $2,199 | $2,400 | $2,400 |
| % Growth | 0% | -8.4% | 0% | – |
| Gross Profit | $2,199 | $2,199 | $2,400 | $2,400 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | $17,645 | $17,645 | $37,073 | $37,073 |
| % Margin | 802.4% | 802.4% | 1,544.9% | 1,544.9% |
| Net Income | $18,044 | $18,044 | $37,770 | $37,770 |
| % Margin | 820.6% | 820.6% | 1,573.9% | 1,573.9% |
| EPS Diluted | 0.45 | 0.45 | 0.94 | 0.94 |
| % Growth | 0% | -52.1% | 0% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |